Gibson Oncology and NIH Launch Phase 2 Trials of LMP744 Targeting First-Time Recurrent Glioblastoma
Gibson Oncology, a Miami-based clinical-stage pharmaceutical company, has announced the commencement of Phase 2 clinical trials for its novel compound ...
